Quick Answer
Neuphoria Therapeutics Inc. reported Total Revenue of $15.65 million for the year ending 2025.
- This data is from Neuphoria Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2025 to 2025 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2024: $662.7 thousand | Q1 2025: $15.00 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: